Market News

NEW YORK & PALO ALTO, Calif.--(BUSINESS WIRE)--TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition Corp. (Nasdaq: TCGX), a special purpose acquisition company (SPAC) sponsored by TCGX, today announced the exec

At least 18 killed in Houthi attack on Yemeni government military camp in Shabwa, sources say Reuters

Iran’s main oil-loading terminals have remained empty for weeks, adding to signs that a US naval blockade of the country is throttling Tehran’s exports.

Partner at firm had said need to approach ‘sophisticated investors’ to back its AI lab ‘probably’ ruled out region’s ‘sovereign wealth money’

TriGemX Bio to go public in $600M TCGX merger

This new crisis looks different and the bloc’s leaders are preparing to talk directly to Putin

Silgan, American Industrial Partners funds to buy Trivium in deal valued at $3.4B

India’s navy is exploring new ways to power future warships so they can carry laser and microwave weapons capable of taking down swarms of cheap drones, according to Vice Admiral Ajay Kochhar.

Centrus Energy to buy Westerman in $116M deal, adding key centrifuge supplier

Andrew Sheets, global head of fixed income research at Morgan Stanley, examines what impact volatility in French bonds and equities may have on European Central Bank policy and how his firm is approaching European markets. He speaks on “Bloomberg Surveillance.” (Source: Bloomberg)